Comparison of the diagnostic accuracy of whole-body MRI and whole-body CT in stage III/IV malignant melanoma;Vergleich der diagnostischen genauigkeit der ganzkörper-MRT und ganzkörper-CT bei malignem melanom im stadium III/IV

JDDG - Journal of the German Society of Dermatology

Volumn 9, Issue 3, 2011, Pages 212-221

  Hausmann, Daniel ^a   Jochum, Susanne ^a,b   Utikal, Jochen ^a   Hoffmann, Richard Christian ^a   Zechmann, Christian ^c   Neff, Kurt Wolfgang ^a   Goerdt, Sergij ^a   Schoenberg, Stefan Oswald ^a   Dinter, Dietmar Jörg ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Institut für Radiologie Westpfalzklinikum Kaiserslautern   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Malignant melanoma; Stage III IV; Staging; Whole body CT; Whole body MRI

Indexed keywords

BARIUM SULFATE; GADOLINIUM PENTETATE; IOMEPROL;

ADULT; AGED; ARTICLE; CANCER STAGING; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LUNG NODULE; MAJOR CLINICAL STUDY; MALE; MELANOMA; OBSERVER VARIATION; OUTCOME ASSESSMENT; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; WHOLE BODY CT; WHOLE BODY MRI;

EID: 79952224228     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2011.07614.x     Document Type: Article

References (41)

1. Garbe C, Leiter U. Melanoma epidemiology and trends. Clin Dermatol 2009; 27(1): 3-9.
2. Garbe C, Schadendorf D, Stolz W, Volkenandt M, Reinhold U, Kortmann RD, Kettelhack C, Frerich B, Keilholz U, Dummer R, Sebastian G, Tilgen W, Schuler G, Mackensen A, Kaufmann A, Hauschild A. Short German guidelines: malignant melanoma. J Dtsch Dermatol Ges 2008; 6 Suppl 1: S9-S14.
3. Schmidt G, Dinter D, Reiser MF, Schoenberg SO. The uses and limitations of whole-body magnetic resonance imaging. Dtsch Arztebl Int 2010; 107(22): 383-9.
4. Forschner A, Eigentler TK, Pflugfelder A, Leiter U, Weide B, Held L, Meier F, Garbe C, Melanoma staging: facts and controversies. Clin Dermatol 2010; 28(3): 275-80.
5. Aukema TS, Olmos RA, Korse CM, Kroon BB, Wouters MW, Vogel WV, Bonfrer JM, Nieweg OE. Utility of FDG PET/CT and brain MRI in melanoma patients with increased serum S-100B level during follow-up. Ann Surg Oncol 2010; 17(6): 1657-61.
6. Laurent V, Trausch G, Bruot O, Olivier P, Felblinger J, Regent D. Comparative study of two whole-body imaging techniques in the case of melanoma metastases: Advantages of multi-contrast MRI examination including a diffusion-weighted sequence in comparison with PET-CT. Eur J Radiol 2010; 75(3): 376-83.
7. Coldman AJ, Major D, Doyle GP, D'Yachkova Y, Phillips N, Onysko J, Shumak R, Smith NE, Wadden N. Organized breast screening programs in Canada: effect of radiologist reading volumes on outcomes. Radiology 2006; 238(3): 809-15. (Pubitemid 43289911)
8. Wadden N, Doyle GP. Breast cancer screening in Canada: a review. Can Assoc Radiol J 2005; 56(5): 271-5. (Pubitemid 43234953)
9. Zijlstra JM, Comans EF, van Lingen A, Hoekstra OS, Gundy CM, Coebergh JW, Bongers V. FDG PET in lymphoma: the need for standardization of interpretation. An observer variation study. Nucl Med Commun 2007; 28(10): 798-803. (Pubitemid 47345712)
10. Smulders SA, Gundy CM, van Lingen A, Comans EF, Smeenk FW, Hoekstra OS. Observer variation of 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography in mediastinal staging of non-small cell lung cancer as a function of experience, and its potential clinical impact. Mol Imaging Biol 2007; 9(5): 318-22. (Pubitemid 47304782)
11. Schmidt GP, M.F. Reiser, and A. Baur-Melnyk, Whole-body MRI for the staging and follow-up of patients with metastasis. Eur J Radiol, 2009. 70(3): 393-400.
12. Dinter DJ, Neff WK, Klaus J, Bohm C, Hastka J, Weiss C, Schoenberg SO, Metzgeroth G. Comparison of whole-body MR imaging and conventional X-ray examination in patients with multiple myeloma and implications for therapy. Ann Hematol 2009; 88(5): 457-64.
13. Schmidt GP, Baur-Melnyk A, Haug A, Heinemann V, Bauerfeind I, Reiser MF, Schoenberg OS. Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PETCT. Eur J Radiol 2008; 65(1): 47-58.
14. Muller-Horvat C, Radny P, Eigentler TK, Schafer J, Pfannenberg C, Horger M, Khorchidi S, Nagele T, Garbe C, Claussen CD, Schlemmer HP. Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma. Eur J Cancer 2006; 42(3): 342-50. (Pubitemid 43132889)
15. Ghanem N, Altehoefer C, Hogerle S, Nitzsche E, Lohrmann C, Schafer O, Kotter E, Langer M. Detectability of liver metastases in malignant melanoma: prospective comparison of magnetic resonance imaging and positron emission tomography. Eur J Radiol 2005; 54(2): 264-70. (Pubitemid 40523619)
16. Brown S, Thorpe H, Hawkins K, Brown J. Minimization - reducing predictability for multi-centre trials whilst retaining balance within centre. Stat Med 2005; 24(24): 3715-27. (Pubitemid 43115727)
17. Soffietti R, Ruda R, Mutani R. Management of brain metastases. J Neurol 2002; 249(10): 1357-69. (Pubitemid 35217656)
18. Kauczor HU, Kreitner KF. Contrast-enhanced MRI of the lung. Eur J Radiol 2000; 34(3): 196-207.
19. Vogt FM, Herborn CU, Hunold P, Lauenstein TC, Schroder T, Debatin JF, Barkhausen J. HASTE MRI versus chest radiography in the detection of pulmonary nodules: comparison with MDCT. AJR Am J Roentgenol 2004. 183(1): 71-8. (Pubitemid 38789014)
20. Diederich S. [Radiological diagnosis of pulmonary metastases: imaging findings and diagnostic accuracy]. Radiologe 2004; 44(7): 663-70.
21. Paulson EK. Evaluation of the liver for metastatic disease. Semin Liver Dis 2001; 21(2): 225-36. (Pubitemid 32552253)
22. Forsberg F, Piccoli CW, Liu JB, Rawool NM, Merton DA, Mitchell DG, Goldberg BB. Hepatic tumor detection: MR imaging and conventional US versus pulse-inversion harmonic US of NC100100 during its reticuloendothelial system-specific phase. Radiology 2002; 222(3): 824-9. (Pubitemid 34215236)
23. Schattevoet WH, Corstens FH, Beex LA, Rosenbusch GJ. [Reliability of sonography in diagnosing liver metastases in breast and bronchial cancer. A retrospective comparison of physical examination, laboratory tests and liver scintigraphy]. Ultraschall Med 1986; 7(6): 293-9.
24. Taupitz M, Hamm B. [Value of MRI in diagnosis of focal liver lesions]. Radiologe 1995; 35(11 Suppl 2): S243-7.
25. Wernecke K, Rummeny E, Bongartz G, Vassallo P, Kivelitz D, Wiesmann W, Peters PE, Reers B, Reiser M, Pircher W. Detection of hepatic masses in patients with carcinoma: comparative sensitivities of sonography, CT, and MR imaging. AJR Am J Roentgenol 1991; 157(4): 731-9.
26. Ghanem N, Kelly T, Altehoefer C, Winterer J, Schafer O, Bley TA, Moser E, Langer M. [Whole-body MRI in comparison to skeletal scintigraphy for detection of skeletal metastases in patients with solid tumors]. Radiologe 2004; 44(9): 864-73.
27. Haubold-Reuter BG, Duewell S, Schilcher BR, Marincek B, von Schulthess GK. The value of bone scintigraphy, bone marrow scintigraphy and fast spin-echo magnetic resonance imaging in staging of patients with malignant solid tumours: a prospective study. Eur J Nucl Med 1993; 20(11): 1063-9. (Pubitemid 23353797)
28. Steinborn MM, Heuck AF, Tiling R, Bruegel M, Gauger L, Reiser MF. Whole-body bone marrow MRI in patients with metastatic disease to the skeletal system. J Comput Assist Tomogr 1999; 23(1): 123-9. (Pubitemid 29095482)
29. Traill ZC, Talbot T, Golding S, Gleeson FV. Magnetic resonance imaging versus radionuclide scintigraphy in screening for bone metastases. Clin Radiol 1999; 54(7): 448-51. (Pubitemid 29355976)
30. Altehoefer C, Ghanem N, Hogerle S, Moser E, Langer M. Comparative detectability of bone metastases and impact on therapy of magnetic resonance imaging and bone scintigraphy in patients with breast cancer. Eur J Radiol 2001; 40(1): 16-23. (Pubitemid 32982905)
31. Ghanem N, Uhl M, Brink I, Schafer O, Kelly T, Moser E, Langer M. Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone. Eur J Radiol 2005; 55(1): 41-55. (Pubitemid 40798487)
32. Ghanem N, Altehoefer C, Kelly T, Lohrmann C, Winterer J, Schafer O, Bley TA, Moser E, Langer M. Wholebody MRI in comparison to skeletal scintigraphy in detection of skeletal metastases in patients with solid tumors. In Vivo 2006; 20(1): 173-82. (Pubitemid 43103737)
33. Plathow C, Walz M, Lichy MP, Aschoff P, Pfannenberg C, Bock H, Eschmann SM, Claussen CD, Schlemmer HP. [Cost considerations for whole-body MRI and PET/CT as part of oncologic staging]. Radiologe 2008; 48(4): 384-96.
34. Biederer J, Hintze C, Fabel M. MRI of pulmonary nodules: technique and diagnostic value. Cancer Imaging 2008; 8: 125-30. (Pubitemid 351767100)
35. Heusner T, Golitz P, Hamami M, Eberhardt W, Esser S, Forsting M, Bockisch A, Antoch G. "One-stop-shop" staging: Should we prefer FDG-PET/CT or MRI for the detection of bone metastases? Eur J Radiol Nov 26. [Epub ahead of print].
36. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst 2010; 102(9): 605-13.
37. Aoyama M, Li Q, Katsuragawa S, Li F, Sone S, Doi K. Computerized scheme for determination of the likelihood measure of malignancy for pulmonary nodules on low-dose CT images. Med Phys 2003; 30(3): 387-94. (Pubitemid 36337105)
38. Dodd LE, Wagner RF, Armato SG, McNitt-Gray MF, Beiden S, Chan HP, Gur D, McLennan G, Metz CE, Petrick N, Sahiner B, Sayre J. Assessment methodologies and statistical issues for computer-aided diagnosis of lung nodules in computed tomography: contemporary research topics relevant to the lung image database consortium. Acad Radiol 2004; 11(4): 462-75. (Pubitemid 38405374)
39. Husband JE, Schwartz LH, Spencer J, Ollivier L, King DM, Johnson R, Reznek R. Evaluation of the response to treatment of solid tumours - a consensus statement of the International Cancer Imaging Society. Br J Cancer 2004; 90(12): 2256-60. (Pubitemid 38961886)
40. Sohaib SA, Turner B, Hanson JA, Farquharson M, Oliver RT, Reznek RH. CT assessment of tumour response to treatment: comparison of linear, cross-sectional and volumetric measures of tumour size. Br J Radiol 2000; 73(875): 1178-84.
41. Huppertz A, Schmidt M, Wagner M, Puettcher O, Asbach P, Strassburg J, Stockmann F, Schoffski O, Maurer MH. Whole-body MR imaging versus sequential multimodal diagnostic algorithm for staging patients with rectal cancer: cost analysis. Rofo 2010; 182(9): 793-802.